Bruce G. Allen Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Bruce G. Allen Investments, LLC
- $132 Billion
- Q2 2025
A detailed history of Bruce G. Allen Investments, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 36 shares of REGN stock, worth $21,600. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36
Previous 40
10.0%
Holding current value
$21,600
Previous $25.4 Million
25.5%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,418Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.65 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.07 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.39 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.9 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.3 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...